Drug intelligence / Profile preview

deproteinized calf blood extract + sodium chloride

Development stage
Unknown
Lead developer
Heilongjiang Jiangshi Pharmaceutical
Administration
Intravenous
01

Overview

Deproteinized calf blood extract + sodium chloride is a biological hemodialysate developed and manufactured by Heilongjiang Jiangshi Pharmaceutical. It consists of a protein-free extract derived from calf blood, containing a complex mixture of low-molecular-weight components such as amino acids, nucleosides, and electrolytes, formulated in a 0.9% sodium chloride solution. The drug is indicated for the treatment of neurological and metabolic disorders, including cerebrovascular diseases, traumatic brain injury, and peripheral circulatory disturbances. Its therapeutic effect is attributed to the enhancement of cellular oxygen utilization and the stimulation of glucose transport and metabolism, which helps maintain cellular energy levels and protects tissues from damage under hypoxic or ischemic conditions. It is administered via intravenous injection and is approved for clinical use in China.

Brand names
Jiangshi
Other names
Deproteinized Calf Blood Extract and Sodium Chloride InjectionDeproteinized Calf Blood Extract with Sodium Chloride Injection脱蛋白牛血提取物氯化钠注射液
02

Targets

SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)

Beyond the preview

Go deeper on deproteinized calf blood extract + sodium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on deproteinized calf blood extract + sodium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call